Favipiravir is influenza/antiviral medicine. It selectively inhibits the RNA polymerase of the influenza virus, an enzyme required for viral replication once human host cells are infected. it is believed that Favipiravir may be effective in treating COVID-19. Favipiravir is only used when there is an outbreak of novel or re-emerging influenza virus infections in which other influenza antiviral drugs are either not effective or insufficiently effective.

Contraindications

Favipiravir is contraindicated for pregnant women and women who may possibly be pregnant.

Indications

Treatment of novel or re-emerging pandemic influenza virus infections (limited to cases in which other influenza antiviral drugs are ineffective or not sufficiently effective).